

A multivariable model with multiple overdoses (vs. Multivariable logistic regression identified childhood household income >$100,00 (AOR=1.88), HCV-positive status (AOR=2.64), benzodiazepine use (AOR=2.15), PO injection (AOR=1.96) and non-sterile syringe use (AOR=1.70) as significant independent correlates of lifetime overdose. $51,000-100,000) lifetime homelessness HCV antibody-positive status lifetime engagement in regular nonmedical benzodiazepine use, regular heroin injection and regular PO injection and using a non-sterile syringe in the past 12 months.

In bivariable analyses, after RDS adjustment, having ever overdosed was correlated with: household income of >$100,00 growing up (vs. The majority of participants’ most recent overdoses (63.5%) were due to polysubstance use. Results: 43.9% of participants reported lifetime overdose experience of these, 58.8% had experienced two or more overdose events. Participants completed structured interviews to assess their socio-demographics, drug use trajectories, current substance use and lifetime and most recent overdose experiences, and were tested on-site for hepatitis C virus (HCV) antibodies. Eligibility criteria included: aged 18–29 years old current residence in NYC and nonmedical prescription opioid (PO) use and/or heroin use in the past 30 days. Methods: 539 participants were recruited via Respondent-Driven Sampling in 2014-2016.

This study examines the experiences and correlates of non-fatal overdose among young adults using illicit opioids in New York City (NYC). Introduction: Rates of illicit opioid use are particularly high among young adults, yet research on overdose experience and factors associated with overdose in this population remains limited. 4Department of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, MA, United States.3Department of Population Health, New York University School of Medicine, New York, NY, United States.2Behavioral Science Training Program in Drug Abuse Research, NYU Rory Myers College of Nursing, New York University, New York, NY, United States.1Institute for Implementation Science in Population Health, CUNY Graduate School of Public Health & Health Policy, New York, NY, United States.Honoria Guarino 1 *, David Frank 2, Kelly Quinn 2,3, Dongah Kim 4, Krista Gile 4, Kelly Ruggles 3, Samuel R.
